No products in the cart.
Gefticip 250 mg
Gefticip 250 mg (Gefitinib)Tablet is using in the therapy of non-small cell lung cancer. It is using in patients in which it has grown to other parts of the body, who have irregular epidermal growth factor receptor (EGFR) genes, and who have not had past cancer treatment.
88.00$ – 448.00$Price range: 88.00$ through 448.00$
| Equivalent Brand | Iressa |
|---|---|
| Generic Name | Gefitinib |
| Indication | Non-small cell lung cancer |
| Strength | Gefitinib (250mg) |
| Manufacturer | Cipla Ltd |
| Packaging | 30 tablets in 1 bottle |
| Pharmaceutical Form | Tablet |





